US9549999B2 - Radiopharmaceutical composition - Google Patents

Radiopharmaceutical composition Download PDF

Info

Publication number
US9549999B2
US9549999B2 US12/677,528 US67752808A US9549999B2 US 9549999 B2 US9549999 B2 US 9549999B2 US 67752808 A US67752808 A US 67752808A US 9549999 B2 US9549999 B2 US 9549999B2
Authority
US
United States
Prior art keywords
tetrofosmin
radiopharmaceutical
radiopharmaceutical composition
radioprotectant
biocompatible
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active, expires
Application number
US12/677,528
Other versions
US20100236958A1 (en
Inventor
Janne Veggeland
Grethe Karin Madsen
Stig Hemsted
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare Ltd
Original Assignee
GE Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US97408907P priority Critical
Priority to GB0718386.6 priority
Priority to GBGB0718386.6A priority patent/GB0718386D0/en
Application filed by GE Healthcare Ltd filed Critical GE Healthcare Ltd
Priority to US12/677,528 priority patent/US9549999B2/en
Priority to PCT/EP2008/062528 priority patent/WO2009037336A2/en
Assigned to GE HEALTHCARE LIMITED reassignment GE HEALTHCARE LIMITED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HEMSTAD, STIG, VEGGELAND, JANNE, MADSEN, GRETHE KARIN
Publication of US20100236958A1 publication Critical patent/US20100236958A1/en
Application granted granted Critical
Publication of US9549999B2 publication Critical patent/US9549999B2/en
Active legal-status Critical Current
Adjusted expiration legal-status Critical

Links